Novavax, Inc. (NVAX) Stock Has Risen 13.54% This Week: Buy, Hold, or Sell?

Novavax, Inc. (NVAX) stock has fallen -77.39% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives NVAX stock a score of 0 out of a possible 100.

That rank is influenced by a short-term technical score of 0. NVAX's rank also includes a long-term technical score of 0.

NVAX has an Overall Score of 0. Find out what this means to you and get the rest of the rankings on NVAX!

See Full NVAX Report

What's Happening with NVAX Stock Today

Novavax, Inc. (NVAX) stock has gained 6.24% while the S&P 500 has risen 0.01% as of 10:07 AM on Wednesday, Jun 22. NVAX has risen $2.58 from the previous closing price of $41.37 on volume of 789,894 shares. Over the past year the S&P 500 is down -11.34% while NVAX has fallen -77.39%. NVAX lost -$17.69 per share in the over the last 12 months. Click Here to get the full Stock Report for Novavax, Inc. stock.